DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,217,000 | +103.2% | 60,386 | +276.1% | 0.00% | – |
| Q2 2021 | $599,000 | +62.3% | 16,054 | +11.5% | 0.00% | – |
| Q1 2021 | $369,000 | +14.2% | 14,396 | -2.0% | 0.00% | – |
| Q4 2020 | $323,000 | +21.9% | 14,691 | -0.6% | 0.00% | – |
| Q3 2020 | $265,000 | -40.8% | 14,783 | -16.2% | 0.00% | – |
| Q2 2020 | $448,000 | +56.6% | 17,645 | +13.4% | 0.00% | – |
| Q1 2020 | $286,000 | -27.0% | 15,557 | -12.6% | 0.00% | – |
| Q4 2019 | $392,000 | +100.0% | 17,808 | +30.3% | 0.00% | – |
| Q3 2019 | $196,000 | +28.9% | 13,666 | +41.6% | 0.00% | – |
| Q2 2019 | $152,000 | +7.8% | 9,649 | 0.0% | 0.00% | – |
| Q1 2019 | $141,000 | +43.9% | 9,649 | +5.0% | 0.00% | – |
| Q4 2018 | $98,000 | -3.0% | 9,186 | +38.7% | 0.00% | – |
| Q3 2018 | $101,000 | +24.7% | 6,625 | 0.0% | 0.00% | – |
| Q2 2018 | $81,000 | – | 6,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
| Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
| EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
| RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
| BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
| Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
| Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
| DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
| EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |